Developmental pathways in breast cancer and breast tumor-initiating cells: therapeutic implications

Julia Izrailit1, Michael Reedijk

  • 1Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, 620 University Avenue, Toronto, Ontario, Canada M5G 2M9.

Cancer Letters
|November 30, 2011
PubMed

Insights

Breast cancer is a complex disease with a hierarchy of cells, including stem-like tumor-initiating cells (TICs). Targeting developmental pathways like Hedgehog, Wnt, and Notch offers a promising approach for personalized cancer therapies.

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Developmental Biology

Background:

  • Breast cancer exhibits molecular heterogeneity with a cellular hierarchy.
  • Tumor-initiating cells (TICs) are crucial for cancer progression and recurrence.
  • Targeted therapies aim to selectively attack cancer-specific processes.

Purpose of the Study:

  • To review the role of developmental pathways in stem cell biology.
  • To survey pre-clinical and clinical trials targeting these pathways in cancer.
  • To highlight novel therapeutic strategies for breast cancer.

Main Methods:

  • Review of scientific literature on developmental pathways (Hedgehog, Wnt, Notch).
  • Analysis of pre-clinical and clinical trial data for targeted therapies.
  • Synthesis of information on stem cell biology and cancer stem cells.

Main Results:

  • Developmental pathways are reactivated in malignancies, supporting the TIC compartment.
  • Targeting these pathways offers a strategy for personalized cancer treatment.
  • Novel therapeutic strategies show promise in pre-clinical and clinical settings.

Conclusions:

  • Understanding developmental pathways in TICs is key to advancing breast cancer therapy.
  • Targeting these pathways represents a significant step towards personalized medicine.
  • Further research and clinical trials are essential to fully realize the potential of these targeted therapies.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...